{
  "id": 15667224,
  "title": "'Groundbreaking Option' Approved for Rectal Cancer",
  "url": "https://urgent.news/2026/10/19/groundbreaking-option-approved-for-rectal-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T21:42:29.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/coloncancer/123473"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA on Monday granted accelerated approval to the PD-1 inhibitor dostarlimab (Jemperli) to help select patients with operable rectal cancer potentially avoid surgery. The approval allows use in stage II/III patients with...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}